Fruquintinib PopPK in Refractory Metastatic CRC
Indication: Metastatic Colorectal Cancer
Interactive population pharmacokinetic simulator for fruquintinib (FRUZAQLA), a selective VEGFR-1/2/3 tyrosine kinase inhibitor for metastatic colorectal cancer. One-compartment model based on Zhou et al. 2025 (J Clin Pharmacol).
Drug Overview
Clinical Context
- Drug Class
- VEGFR Tyrosine Kinase Inhibitor
- Therapeutic Area
- Metastatic Colorectal Cancer
- Indication
- Metastatic Colorectal Cancer
- Route of Administration
- Oral
Model Information
- Model Type
- PopPK
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for Fruquintinib allows you to explore concentration-time profiles under different dosing scenarios. The underlying PopPK model characterizes the pharmacokinetics of this vegfr tyrosine kinase inhibitor following oral administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the Fruquintinib PK simulator?
This is a free, interactive pharmacokinetic simulator for Fruquintinib used in Metastatic Colorectal Cancer. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does Fruquintinib belong to?
Fruquintinib is classified as a VEGFR Tyrosine Kinase Inhibitor. It is used in the Metastatic Colorectal Cancer therapeutic area.
What route of administration does this model simulate?
This simulator models Oral administration of Fruquintinib. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a PopPK model. Population PK models account for interindividual variability and covariate effects on drug exposure.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Ready to Simulate?
Launch the Fruquintinib simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community